Anthropic Acquires Coefficient Bio for $400M as AI Enters Drug Discovery
Anthropic's $400M acquisition of AI biotech startup Coefficient Bio signals a major shift - AI labs are no longer just building models, they're targeting entire industries. Here's what it means for the future of life sciences.
Claude Mythos Leaked: Anthropic's Secret 'Most Capable' Model Exposed Online
Unpublished files describing Anthropic's Claude Mythos, internally dubbed the company's most capable AI model, leaked online this week, raising questions about internal security and the competitive AI model race.
Claude Code's Source Leaked. The Web Is Now an Attack Surface.
Anthropic's Claude Code source was leaked via npm. Google warns the open web is the #1 attack vector for AI agents. Prompt injections hit 86% success.
ARC-AGI-3 Benchmark Shatters AGI Hype: Top Models Score Below 1%
The ARC-AGI-3 benchmark tested whether AI agents can generalize in unknown environments. Top models scored under 1% while humans solved 100%. The verdict: AGI is nowhere near here.
Anthropic Forms AnthroPAC — The AI Company Goes Political
Anthropic files with the FEC to launch a political action committee, escalating the AI policy wars as the company battles the Trump administration in federal court.
Anthropic Acquires AI Biotech Startup Coefficient Bio for $400M
Anthropic is pushing beyond general-purpose AI with its $400M acquisition of Coefficient Bio, a startup applying AI to drug discovery and clinical workflows. The move signals AI's expansion into high-stakes scientific domains.
Tech Roundup: Microsoft $10B Japan Bet, SpaceX $75B IPO, Pentagon vs Anthropic
Microsoft invests $10B in Japan AI infra, SpaceX seeks record $75B IPO, Trump admin appeals ruling blocking action against Anthropic.